Yuliang Ran
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Cancer, Hypoxia, and Metabolism 11
- Oncology 23
- Cancer Cells and Metastasis 11
- Peptidase Inhibition and Analysis 7
- HER2/EGFR in Cancer Research 6
Yuliang Ran
52 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 348
- Biomaterials 228
- Oncology 345
- Molecular Biology 689
- Immunology and Allergy 55
Countries citing papers authored by Yuliang Ran
This map shows the geographic impact of Yuliang Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuliang Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuliang Ran more than expected).
Fields of papers citing papers by Yuliang Ran
This network shows the impact of papers produced by Yuliang Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuliang Ran. The network helps show where Yuliang Ran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuliang Ran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 6 | |
| 8 | 2021 | 40 | |
| 9 | 2021 | 44 | |
| 10 | 2021 | 10 | |
| 11 | 2019 | 1 | |
| 12 | 2018 | 31 | |
| 13 | 2017 | 28 | |
| 14 | 2016 | 31 | |
| 15 | 2012 | 22 | |
| 16 | 2012 | 21 | |
| 17 | 2011 | 19 | |
| 18 | 2009 | 71 | |
| 19 | 2008 | 22 | |
| 20 | 2006 | 7 |
About Yuliang Ran
Yuliang Ran is a scholar working on Cancer Research, Oncology, Immunology and Allergy, Biotechnology and Molecular Biology, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), Cancer, Hypoxia, and Metabolism (11 papers), Peptidase Inhibition and Analysis (7 papers), HER2/EGFR in Cancer Research (6 papers), Angiogenesis and VEGF in Cancer (6 papers), Cancer-related gene regulation (6 papers), Cancer Research and Treatments (6 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Cancer Research (348 citations), Biomaterials (228 citations), Oncology (345 citations), Molecular Biology (689 citations) and Immunology and Allergy (55 citations). Yuliang Ran has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhuan Zhou, Lichao Sun, Mingyuan Gao, Long Yu, Fangqin Hu, Zhongrui Li, Lusha Wei, Lixin Sun, Zhihua Yang and Zhihua Yang. Their work appears in journals such as Clinical Cancer Research, International Journal of Medical Sciences, Molecular & Cellular Proteomics, International Journal of Oncology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.